➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Mallinckrodt
AstraZeneca
Boehringer Ingelheim
McKinsey
Johnson and Johnson
McKesson

Last Updated: September 28, 2020

DrugPatentWatch Database Preview

Patent: 10,046,288

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 10,046,288
Title:View definition enhancement system and method for gastrointestinal endoscope diagnosis and treatment
Abstract: A view definition enhancement system for gastrointestinal endoscope diagnosis and treatment (ESCGV) comprises a washing bottle (1) and a liquid delivery pipe (2) led out from the washing bottle (1). The liquid delivery pipe (2) pumps washing liquid to a liquid inlet system of a gastrointestinal endoscope or an observation window of the gastrointestinal endoscope through a first peristaltic pump (3); and the washing bottle (1) is further provided with a stirring and heating subsystem capable of stirring and heating the washing liquid. A view definition enhancement method for gastrointestinal endoscope diagnosis and treatment comprises steps of: 1) adding the washing liquid into the washing bottle (1); 2) magnetically stirring the washing liquid in the washing bottle (1), and heating the washing liquid at the same time; 3) setting the temperature of the washing liquid to 25-38.degree. C.; and 4) delivering the washing liquid into the observation window of the gastrointestinal endoscope. The ESCGV can enhance the view definition under the gastrointestinal endoscope, make the operation simple and convenient, reduce the missed diagnosis and erroneous diagnosis, and improve the treatment quality of the gastrointestinal endoscope.
Inventor(s): Wang; Guohua (Chongqing, CN), Liu; Aling (Chongqing, CN), Wang; Zhexi (Chongqing, CN)
Assignee: CHONGQING SKYFORBIO CO., LTD. (Chongqing, CN)
Application Number:14/397,057
Patent Claims:see list of patent claims

Details for Patent 10,046,288

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Merck Sharp & Dohme Corp. ZOSTAVAX zoster vaccine live INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION 125123 001 2006-05-25   Start Trial CHONGQING SKYFORBIO CO., LTD. (Chongqing, CN) 2032-04-25 search
Merck Sharp & Dohme Corp. ZOSTAVAX zoster vaccine live INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION 125123 1 2006-05-25   Start Trial CHONGQING SKYFORBIO CO., LTD. (Chongqing, CN) 2032-04-25 search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Johnson and Johnson
Moodys
McKesson
Boehringer Ingelheim
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.